S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
CarMax Slides On Earnings Disappointment, Time To Celebrate?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Will the Energy Sector Continue to Outshine the Market?
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Fraud Expert: Dump these three popular stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Fraud Expert: Dump these three popular stocks (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
CarMax Slides On Earnings Disappointment, Time To Celebrate?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Will the Energy Sector Continue to Outshine the Market?
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Fraud Expert: Dump these three popular stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Fraud Expert: Dump these three popular stocks (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
CarMax Slides On Earnings Disappointment, Time To Celebrate?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Will the Energy Sector Continue to Outshine the Market?
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Fraud Expert: Dump these three popular stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Fraud Expert: Dump these three popular stocks (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
CarMax Slides On Earnings Disappointment, Time To Celebrate?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Will the Energy Sector Continue to Outshine the Market?
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Fraud Expert: Dump these three popular stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Fraud Expert: Dump these three popular stocks (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
NASDAQ:SNY

Sanofi (SNY) SEC Filings & 10K Form

$53.64
+0.63 (+1.19%)
(As of 09/29/2023 ET)
Compare
Today's Range
$53.43
$53.97
50-Day Range
$50.95
$55.20
52-Week Range
$38.01
$57.82
Volume
3.95 million shs
Average Volume
1.21 million shs
Market Capitalization
$135.66 billion
P/E Ratio
18.37
Dividend Yield
2.57%
Price Target
$60.00

Recent Sanofi SEC Filings

DateFilerForm TypeView
09/27/2023
5:06 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
5:19 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/10/2023
8:50 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2023
2:35 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2023
8:18 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2023
6:00 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2023
11:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/05/2023
7:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
1:31 PM
Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/28/2023
1:32 PM
Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/20/2023
9:18 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
9:53 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
10:15 AM
Sanofi (Filer)
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/23/2023
12:01 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2023
10:39 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2023
8:32 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2023
5:16 AM
Provention Bio, Inc. (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
04/26/2023
5:16 AM
Provention Bio, Inc. (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
04/24/2023
8:55 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2023
12:02 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2023
3:38 PM
Provention Bio, Inc. (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
03/30/2023
12:36 PM
Sanofi (Filer)
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2023
6:10 AM
Provention Bio, Inc. (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T
03/17/2023
3:16 PM
Provention Bio, Inc. (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
03/14/2023
11:05 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2023
10:40 AM
Sanofi (Filer)
Sanofi (Filer)
Form S-8 POS
03/13/2023
6:38 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2023
10:57 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2023
4:20 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2023
9:25 AM
Sanofi (Filer)
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/21/2023
11:52 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2023
1:22 PM
DODGE & COX (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
02/10/2023
3:49 PM
Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
02/07/2023
1:10 PM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
02/03/2023
10:40 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2023
12:03 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2023
1:07 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2022
5:13 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2022
9:40 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2022
9:05 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2022
2:01 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/10/2022
1:00 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2022
10:16 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/17/2022
12:35 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2022
10:24 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNY) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -